Surgical and amyloidosis specialty clinics; acute hospital setting for postoperative complications
Key Highlights
Amyloidosis is a rare but important cause of small bowel perforation in patients with IBD.
Bariatric surgery, including RYGB, is increasingly performed in patients with co-morbid obesity and IBD with comparable complication rates to non-IBD patients.
Apolipoprotein A-IV type amyloidosis can present post-RYGB with small bowel perforation requiring surgical revision.
Guideline-Based Recommendations
Diagnosis
Consider amyloidosis in differential diagnosis of small bowel perforation in IBD patients post-bariatric surgery.
Use histopathological analysis with Congo red staining and polarization microscopy to confirm amyloid deposition.
Subtype amyloid deposits via liquid chromatography–mass spectrometry for accurate classification.
Management
Prompt surgical intervention for small bowel perforation, including resection of affected bowel and revision of anastomosis.
Perioperative discontinuation of immunosuppressive therapy (e.g., adalimumab) as appropriate.
Postoperative multidisciplinary follow-up including amyloidosis clinic for systemic evaluation.
Monitoring & Follow-up
Screen for common systemic amyloid complications such as cardiac and renal involvement postoperatively.
Monitor inflammatory markers and clinical symptoms to assess disease progression or recurrence.
Regular surgical follow-up to evaluate recovery and symptom control.
Risks
Potential for small bowel perforation due to amyloid infiltration in patients with IBD undergoing RYGB.
Risk of postoperative complications including adhesions and obstruction.
Persistent symptoms such as fatigue despite surgical resolution of perforation.
Patient & Prescribing Data
Middle-aged female with Crohn’s disease and rheumatoid arthritis undergoing conversion from sleeve gastrectomy to RYGB.
Discontinuation of adalimumab perioperatively; surgical revision effective in managing perforation; ongoing symptom monitoring necessary.
Clinical Best Practices
Preoperative comprehensive evaluation including endoscopy and exclusion of contraindications such as infections and endocrine disorders.
Design of surgical anatomy (e.g., longer common limb) to accommodate potential future resections in IBD patients.
Multidisciplinary approach involving gastroenterology, surgery, and amyloidosis specialists for optimal patient outcomes.
A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.
